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A b s t r a c t 
 
Aims: The role of gut microbiota in the pathogenesis of diabetes is increasing; this 
study investigates the effect of multi-strain probiotics on fasting plasma glucose 
(FPG), plasma insulin and lipid profile among patients. 
Methods: This randomized double blind controlled trial was performed among 60 
patients; individuals were randomly assigned into 2 groups of 30 participants in order 
to take either probiotic supplements or placebo for 6 weeks. The probiotic 
supplement consisted of 7 viable strains Lactobacillus, Bifidobacterium and 
Streptococcus. Nutrient intakes were estimated using a 3-day and 24 hour-dietary 
recall at the beginning and end of study. Fasting blood samples were taken before and 
after intervention to measure the levels of FPG, plasma insulin and lipid profiles. 
Results: Within group comparisons showed significant decrease and increase in the 
levels of FPG (P ¼ 0.001) and HDL-C (P ¼ 0.002) in probiotic group, respectively. 
No significant alterations were observed for within and between group comparisons 
in the levels of insulin, triglycerides, total cholesterol, insulin resistance and 
anthropometric measurements, including weight, waist circumference and body mass 
index (all P > 0.05). Conclusions: This study showed a significant decrease in FPG 
level by multi-strain probiotic supplements in within group comparison; though, 
further studies are needed to confirm results. (IRCT Code: IRCT2013100714925N1) 
